Skye Bioscience, Inc.

SKYE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G Oct 14, 2026
4 Sep 24, 2026
SCHEDULE 13D/A Sep 24, 2026
4 Sep 24, 2026
4 Sep 18, 2026
4 Sep 18, 2026
DEFA14A Sep 11, 2026 DEFA14A
8-K Sep 11, 2026 8-K
DEFA14A Aug 24, 2026 DEFA14A
8-K Aug 24, 2026 8-K
4 Aug 20, 2026
4 Aug 20, 2026
DEFA14A Aug 20, 2026 DEFA14A
8-K/A Aug 20, 2026 8-K/A
DEFA14A Aug 19, 2026 DEFA14A
8-K Aug 19, 2026 8-K
SCHEDULE 13D/A Aug 18, 2026
DEFA14A Aug 14, 2026 DEFA14A
10-Q Aug 14, 2026 10-Q
8-K Aug 14, 2026 8-K
4 Aug 7, 2026 FORM 4
8-K Jun 23, 2026 8-K
8-K May 29, 2026 8-K
8-K May 15, 2026 8-K
10-Q May 11, 2026 10-Q
← Newer Page 1 of 26 · 629 filings Older →